HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 224 filers reported holding HORIZON PHARMA PLC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $210,000 | -41.0% | 10,743 | -50.0% | 0.08% | -39.0% |
| Q2 2018 | $356,000 | -21.8% | 21,481 | -33.0% | 0.12% | -20.6% |
| Q1 2018 | $455,000 | -2.8% | 32,060 | 0.0% | 0.16% | -3.1% |
| Q4 2017 | $468,000 | +14.4% | 32,060 | -0.7% | 0.16% | +7.4% |
| Q3 2017 | $409,000 | +107.6% | 32,292 | +94.7% | 0.15% | +112.9% |
| Q2 2017 | $197,000 | -22.1% | 16,587 | -3.0% | 0.07% | -19.5% |
| Q1 2017 | $253,000 | -8.7% | 17,106 | 0.0% | 0.09% | -13.9% |
| Q4 2016 | $277,000 | -10.6% | 17,106 | 0.0% | 0.10% | -14.4% |
| Q3 2016 | $310,000 | -16.9% | 17,106 | +59.2% | 0.12% | -28.0% |
| Q2 2015 | $373,000 | -13.1% | 10,742 | -35.0% | 0.16% | -11.8% |
| Q1 2015 | $429,000 | +101.4% | 16,527 | 0.0% | 0.19% | +89.8% |
| Q4 2014 | $213,000 | +21.7% | 16,527 | +16.0% | 0.10% | +10.1% |
| Q3 2014 | $175,000 | – | 14,242 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |